Search

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Why conversations on gender in drug development must go further.

Fake tweet announcing free insulin leads to mayhem.

Unregulated drugs being sold and distributed by the online retailer come under fire.

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Is now finally the time for Alzheimer’s drug development to shine?

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Post-COVID-19, pharma has a better opportunity than ever before to get closer to patients.

Investing in a robust, fulfilling company culture is the best way to thrive in the current challenging recruitment landscape and to achieve long-term